PMID: 8632706Jan 1, 1996Paper

Pharmacokinetic and pharmacodynamic optimization of intraperitoneal chemotherapy

Life Sciences
J P Balthasar, H L Fung


Intraperitoneal drug administration has been utilized to increase chemotherapeutic exposure to tumors confined to the peritoneal cavity, such as those found in ovarian, gastric, colo-rectal and mesotheliomal cancers. Extensive pre-clinical and clinical experimentation has been conducted to assess the pharmacokinetic and therapeutic benefits of this mode of therapy. Pharmacokinetic studies have shown that the barrier function of the peritoneal membrane may be utilized to produce large, favorable concentration gradients between peritoneal perfusate and blood. However, most clinical studies so far have demonstrated minimal increases in drug efficacy or decreases in drug toxicities from intraperitoneal drug therapy alone. This paper reviews the application of adjunctive therapies that have been rationally conceived to optimize intraperitoneal drug therapy through the alteration of antineoplastic pharmacokinetics and pharmacodynamics.


Mar 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·G M HahnI Har-Kedar
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E B Mechetner, I B Roninson
Mar 1, 1990·Gynecologic Oncology·P PfeifferK Bertelsen
Jun 15, 1989·Cancer·M J Wizenberg
Jan 1, 1985·International Journal of Nuclear Medicine and Biology·R E GibsonR Eng
Nov 1, 1986·Journal of Pharmaceutical Sciences·R L Dedrick
Jan 1, 1985·Journal of Oral Rehabilitation·S E WidmalmJ H Lillie
Dec 1, 1982·Annals of Internal Medicine·S B HowellM Green
Nov 1, 1994·Clinical Pharmacokinetics·K D Bagshawe
Dec 1, 1993·International Journal of Radiation Oncology, Biology, Physics·K A LeopoldM W Dewhirst
May 1, 2013·Angewandte Chemie·Gang LiuHui-Ming Cheng


Nov 10, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·K NishidaJ Nakamura
Mar 17, 2012·Clinical Pharmacokinetics·Csilla Hasovits, Stephen Clarke
Mar 27, 2007·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Pierre-Emmanuel ColomboM Vert
Dec 13, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B J Monk, J K Chan

Related Concepts

Antineoplastic Agents
Drug Carriers
Parenteral Infusion
Peritoneal Neoplasms

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.